ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EGRX Eagle Pharmaceuticals Inc

4.05
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:01:51
15분 지연
기업명 주식 심볼 시장 주식 타입
Eagle Pharmaceuticals Inc EGRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.05 17:01:51
개장가 저가 고가 종가 전일 종가
4.05
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/03/202406:49EDGAR2Form 8-K - Current report
02/03/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202421:35EDGAR2Form 8-K - Current report
01/03/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202422:09EDGAR2Form 8-K - Current report
15/02/202407:09EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/02/202405:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:50EDGAR2Form 8-K - Current report
09/02/202419:45PRNUSEagle Pharmaceuticals, Inc. Securities Fraud Class Action..
07/02/202423:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/02/202407:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/01/202419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/01/202419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
18/01/202420:56EDGAR2Form 8-K - Current report
18/01/202420:50GLOBEEagle Pharmaceuticals Provides Update on Bendamustine..
16/01/202421:00EDGAR2Form 8-K - Current report
12/01/202419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
10/01/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
23/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:15EDGAR2Form 8-K/A - Current report: [Amend]
21/12/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/12/202307:11EDGAR2Form 8-K - Current report
07/12/202306:26EDGAR2Form 8-K - Current report
07/12/202306:05GLOBEEagle Pharmaceuticals to Present Abstract on Post-hoc..
29/11/202321:39EDGAR2Form 8-K - Current report
29/11/202321:36EDGAR2Form 8-K - Current report
10/11/202307:23EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202321:57EDGAR2Form 8-K - Current report
09/11/202321:30GLOBEEagle Delays Third Quarter 2023 Results and Conference Call
08/11/202322:30GLOBEEagle Pharmaceuticals to Host Third Quarter 2023 Financial..
04/11/202305:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202305:53EDGAR2Form 144 - Report of proposed sale of securities
02/11/202306:02EDGAR2Form 144 - Report of proposed sale of securities
01/11/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202321:49EDGAR2Form 8-K - Current report
24/10/202321:40GLOBEEagle Pharmaceuticals Granted Patent for PEMFEXY®
23/10/202320:10EDGAR2Form 8-K - Current report
23/10/202319:50GLOBEEagle Pharmaceuticals Granted Unique J-Code and Pass-Through..
05/10/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202319:50GLOBEEagle Pharmaceuticals Awarded First Prize for Poster to Be..
04/10/202305:48EDGAR2Form 144 - Report of proposed sale of securities
03/10/202305:51EDGAR2Form 144 - Report of proposed sale of securities
27/09/202320:00EDGAR2Form 8-K - Current report
20/09/202305:05GLOBEEagle Pharmaceuticals to Present at the Cantor Global..
11/09/202319:50GLOBEEagle Pharmaceuticals to Present CAL02 Trial in Progress at..

최근 히스토리

Delayed Upgrade Clock